Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19.
T ShioharaYoshiko MizukawaPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)